960 x 350_41

Central Laboratory PBMC and BMMC Services

Global processing of peripheral blood mononuclear cells (PBMCs) and bone marrow mononuclear cells (BMMCs)

At Q2 Solutions, we offer the processing of peripheral blood mononuclear cells (PBMCs) and bone marrow mononuclear cells (BMMCs) at our central laboratories across the world. All our processes are performed to globally harmonized standards ensuring consistently high yields, viability and recovery.

  • Our extensive lab network ensures that blood samples are routinely delivered and processed within 24 hours (96% of deliveries agreed to be shipped within 24h arrive on time)
  • We offer processing of variety of tube types and anticoagulants (Cell Preparation tube - CPT, with Sodium Heparin and Sodium Citrate tubes) and, for whole blood, ficoll gradient extraction anticoagulants including Sodium Heparin, EDTA and Acid Citrate Dextrose (ACD)
  • All our processes are performed to global Standard Operation Procedures (SOPs)
  • All our staff members are highly trained and participate regularly in global competency testing
  • Our specialty processing departments offer bespoke solutions to client requirements (such as normalization of cell numbers to specific concentrations, different freezing media, dry cell pellets, differing PBMC extraction methodologies)
  • Select laboratories are PBMC extraction qualified from Cellular Technology Limited (CTL), guaranteeing the highest standard of PBMC extraction and cryopreservation. This allows us to offer serum-free generation of PBMCs on reconstitution, ideal for functional downstream assays such as Elispot
  • From whole blood Streck tubes, we offer plasma processing for the generation of cfDNA, ctDNA and cfRNA
  • Bespoke enrichment assays are available (e.g. CD4+, CD19+, CD34+, CD138+)
  • Custom aliquoting requirements are implemented into clinical trials as appropriate


Global PBMC Network - 24-Hour Global Transit Time Map

PBMC and BMMC Services  map

Specialty processing departments offering bespoke solutions to meet client requirements

Related Thought Leaders Insights


Ensemble-based method for detecting differential expression in RNA datasets provides greater sensitivity and less biased p-values than existing methods

In examining two-group differential analysis, it is apparent that different statistical methods can yield very different results even given the same RNA-Seq input data. In particular, we have...

Assay development, validation, and manufacturing with built-in quality controls

With more than 25 years of experience, Rules-Based Medicine, a Q2 Solutions company develops, validates and manufactures its assays with integrity and commitment for the most reliable, reproducible...

Unleashing the power of MHC Associated Peptide Proteomics: Immunogenicity Assessment of Oncology Drugs

By Chloe Ackaert, Jana Schockaert, Aurelie Mazy, Martijn Vlaming, and Sofie PattynPresented at the American Association for Cancer Research (AACR) Annual Meeting, April 5-10, 2024 Bispecifics...